Cite
MLA Citation
Francois Curtin et al.. “A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti‐HERV‐W‐Env monoclonal antibody.” Diabetes, obesity & metabolism, vol. 20, no. 9, 2018, pp. 2075–2084. http://access.bl.uk/ark:/81055/vdc_100066557789.0x000022